- Titre
- Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations Associated with First-Line Stavudine-Containing Antiretroviral Therapy: Programmatic Implications for Countries Phasing Out Stavudine
- Créateurs - sans rôle
- Michele W Tang - Stanford UniversitySoo-Yon Rhee - Stanford UniversityKiat Ruxrungtham - Department of Medicine, Chulalongkorn University, and Thai Red Cross AIDS Research Center, Bangkok, ThailandClaudia A Hawkins - Northwestern University, Chicago, Illinois, United StatesCarole L Wallis - Lancet LaboratoriesWendy Stevens - University of the WitwatersrandGert U. Van Zyl - Division of Medical Virology, Stellenbosch University, Tygerberg, Cape Town, South AfricaWeerawat Manosuthi - Bamrasnaradura Infectious Diseases InstituteMina C Hosseinipour - University of North Carolina Project, Kamuzu Central Hospital, Lilongwe, MalawiNicole NGO-GIANG-HUONG - Institut de Recherche pour le Developpement IRD U174, Program for HIV Prevention and Treatment, Chiang Mai, ThailandLaurent Belec - Hôpital Européen Georges-PompidouMartine Peeters - UMI233, TransVIHMI, Institut de Recherche pour le Développement (IRD) and Université Montpellier 1, Montpellier, FranceSilvia Bertagnolio - WHO/HTM/TCO, Geneva, SwitzerlandAvelin Aghokeng - UMI233, TransVIHMI, Institut de Recherche pour le Développement (IRD) and Université Montpellier 1, Montpellier, FranceTorsak Bunupuradah - HIV Netherlands Australia Thailand Research CollaborationSherri Burda - Department of Pathology, New York University School of Medicine, New York, New York, United StatesPatricia Cane - Health Protection Agency, London, United KingdomGiulia Cappelli - Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, CameroonCharlotte Charpentier - Université Paris DiderotAnoumou Y Dagnra - Centre National de Reference des tests VIH-IST/PNLS and Laboratoire BIOLIM, FMMP/UL, Lomé, TogoAlaka K Deshpande - Division Infectious Diseases, Department of Medicine, Stanford University, California, United StatesZiad EL-KATIB - Division Infectious Diseases, Department of Medicine, Stanford University, California, United StatesSusan H Eshleman - Stanford UniversityNathan Ford - WHO/HTM/TCO, Geneva, SwitzerlandJoseph Fokam - Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, CameroonJean-Chrysostome Gody - Division Infectious Diseases, Department of Medicine, Stanford University, California, United StatesDavid Katzenstein - Stanford UniversityDonato D Koyalta - Division Infectious Diseases, Department of Medicine, Stanford University, California, United StatesJohnstone J Kumwenda - Division Infectious Diseases, Department of Medicine, Stanford University, California, United StatesMarc Lallemant - Institut de Recherche pour le Developpement IRD U174, Program for HIV Prevention and Treatment, Chiang Mai, ThailandLutgarde Lynen - Division Infectious Diseases, Department of Medicine, Stanford University, California, United StatesVincent C Marconi - Stanford UniversityNicolas A Margot - Stanford UniversitySandrine Moussa - Division Infectious Diseases, Department of Medicine, Stanford University, California, United StatesSusan Holmes - Stanford UniversityThumbi NDUNG'U - Division Infectious Diseases, Department of Medicine, Stanford University, California, United StatesPhillipe N Nyambi - Stanford UniversityCatherine Orrell - Division Infectious Diseases, Department of Medicine, Stanford University, California, United StatesJonathan M Schapiro - Division Infectious Diseases, Department of Medicine, Stanford University, California, United StatesRob Schuurman - Division Infectious Diseases, Department of Medicine, Stanford University, California, United StatesSunee Sirivichayakul - Chulalongkorn UniversityDavey Smith - Division Infectious Diseases, Department of Medicine, Stanford University, California, United StatesMaria Zolfo - Division Infectious Diseases, Department of Medicine, Stanford University, California, United StatesMichael R Jordan - Stanford UniversityRobert W Shafer - Stanford UniversityKim C Sigaloff - University of AmsterdamRaph L Hamers - PharmAccess Foundation, Department of Global Health, Academic Medical Center of the University of Amsterdam, Amsterdam Institute for Global Health and Development, NetherlandsTobias F. Rinke DE WIT - University of AmsterdamHerve J Fleury - Laboratoire de Virologie (WHO accredited), CHU de Bordeaux, Bordeaux, FrancePhyllis J Kanki - Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States
- Détails de publication
- The Journal of infectious diseases, Vol.207
- Éditeur
- Oxford University Press
- Identifiants
- 99158654309311
- Unité académique
- Recherches translationnelles sur le VIH et les Maladies Infect. Endém. émerg. - TransVIHMI
- Langue
- English
- Type de ressource
- Journal article
Article de revue
Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations Associated with First-Line Stavudine-Containing Antiretroviral Therapy: Programmatic Implications for Countries Phasing Out Stavudine: THE IMPACT OF HIV DRUG RESISTANCE ON THE SELECTION OF 1ST-AND 2ND-LINE ART IN RESOURCE-LIMITED SETTINGS
The Journal of infectious diseases, Vol.207
2013
Indicateurs
1 Consultations de la notice